These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29538611)
1. Acinar-Predominant Pattern Correlates With Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung. Lin G; Li H; Kuang J; Tang K; Guo Y; Han A; Xie C Am J Clin Pathol; 2018 Mar; 149(5):373-378. PubMed ID: 29538611 [TBL] [Abstract][Full Text] [Related]
2. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors. Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544 [TBL] [Abstract][Full Text] [Related]
3. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†. Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287 [TBL] [Abstract][Full Text] [Related]
4. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas. Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260 [TBL] [Abstract][Full Text] [Related]
5. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor. Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687 [TBL] [Abstract][Full Text] [Related]
6. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Nie K; Nie W; Zhang YX; Yu H Cancer Imaging; 2019 Jul; 19(1):47. PubMed ID: 31292000 [TBL] [Abstract][Full Text] [Related]
8. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung. Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma. Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421 [TBL] [Abstract][Full Text] [Related]
10. Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma. Chen J; Qi L; Wang J; Xue L; Xue Q; Jia J; Zhang G; Liu J; Li F; Cui S Clin Respir J; 2024 Mar; 18(3):e13743. PubMed ID: 38529681 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung. Kim M; Chung YS; Kim KA; Shim HS Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis. Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008 [TBL] [Abstract][Full Text] [Related]
13. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification. Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551 [TBL] [Abstract][Full Text] [Related]
14. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma. Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma. Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas. Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database. Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397 [TBL] [Abstract][Full Text] [Related]
18. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488 [TBL] [Abstract][Full Text] [Related]
19. Invasive mucinous adenocarcinoma of the lung: clinicopathological features, Sun X; Zeng B; Tan X; Chen Z; Pan X; Jiang L Ann Nucl Med; 2023 Mar; 37(3):198-207. PubMed ID: 36538165 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma. Jeon HW; Kim YD; Sim SB; Moon MH Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]